WebMay 26, 2016 · The long-established Trial of Org 10172 in Acute Stroke Treatment (TOAST) diagnostic algorithm 17,18 is beginning to be superseded by the newer ASCOD (atherosclerosis, small-vessel disease,... WebIn this investigator-initiated, open-label, multicenter trial, we randomly assigned participants in a 1:1 ratio to undergo ambulatory ECG monitoring with a 30-day event-triggered loop …
Implantable cardiac monitors to detect atrial fibrillation
WebAs evidenced in CRYSTAL AF trial, continuous monitoring beyond 30 days with the Reveal Insertable Cardiac Monitor is superior to standard medical care for AF detection in patients with cryptogenic stroke. 8 Key findings included: • 7.3 percent more patients with AF detected at one year than standard medical care WebThe CRYSTAL AF trial design has been described in detail elsewhere.3,12 The study protocol was approved by all relevant institutional review boards or ethics committees, and all patients pro-vided written informed consent before randomiza-tion. The trial is registered under CRYSTAL AF scratch soft98
Cryptogenic Stroke and Underlying Atrial Fibrillation
WebBackground: Since the CRYSTAL-AF trial, implantation and usage of implantable loop recorder (ICM) after cryptogenic stroke (CS) for detection of atrial fibrillation (AF) has increased. However, it is unclear which CS patients would most benefit from long term ICM monitoring. This study aims to determine the risk factors in patients that would confer … WebApr 11, 2024 · The HAVOC score was previously developed to predict the risk of atrial fibrillation (AF) after cryptogenic stroke (CS) or transient ischemic attack (TIA). The … WebDec 6, 2024 · Patients were randomly assigned 1:1 to 5 mg of apixaban twice daily (2.5 mg twice daily for patients ≥80 years of age, weight ≤60 kg, or both) or dose-adjusted warfarin. The primary outcome was time to major or clinically relevant nonmajor bleeding. Secondary outcomes included stroke, mortality, and apixaban pharmacokinetics. scratch socket